We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEGH icon
526
Legacy Housing
LEGH
$629M
$501K 0.04%
19,879
+4,464
+29% +$113K
TGI
527
DELISTED
Triumph Group
TGI
$500K 0.04%
+19,733
New +$457K
LMAT icon
528
LeMaitre Vascular
LMAT
$2.37B
$496K 0.04%
+5,913
New +$550K
REPX icon
529
Riley Exploration Permian
REPX
$728M
$487K 0.03%
16,698
-8,681
-34% -$279K
HIPO icon
530
Hippo Holdings
HIPO
$777M
$485K 0.03%
+18,956
New +$526K
SNOW icon
531
Snowflake
SNOW
$98.1B
$482K 0.03%
+3,300
New +$560K
LUNG icon
532
Pulmonx
LUNG
$52.8M
$482K 0.03%
71,637
+22,259
+45% +$158K
ETNB
533
DELISTED
89bio
ETNB
$480K 0.03%
66,088
-14,830
-18% -$130K
NGS icon
534
Natural Gas Services Group
NGS
$457M
$480K 0.03%
21,839
+6,924
+46% +$175K
KGC icon
535
Kinross Gold
KGC
$27.7B
$479K 0.03%
37,969
-28,285
-43% -$317K
BAND
536
Bandwidth Inc
BAND
$1.19B
$470K 0.03%
+35,901
New +$587K
MWA icon
537
Mueller Water Products
MWA
$3.94B
$467K 0.03%
18,357
-50,459
-73% -$1.27M
IMXI icon
538
International Money Express
IMXI
$389M
$464K 0.03%
+36,769
New +$629K
BJRI icon
539
BJ's Restaurants
BJRI
$1.47B
$462K 0.03%
13,492
AMCX icon
540
AMC Global Media
AMCX
$450M
$461K 0.03%
67,051
+34,419
+105% +$288K
CLBK icon
541
Columbia Financial
CLBK
$1.14B
$461K 0.03%
+30,752
New +$477K
UTL icon
542
Unitil
UTL
$989M
$461K 0.03%
7,990
WVE icon
543
Wave Life Sciences
WVE
$1.12B
$452K 0.03%
55,918
-13,302
-19% -$145K
MTW icon
544
Manitowoc
MTW
$491M
$447K 0.03%
52,007
+24,459
+89% +$238K
NABL icon
545
N-able
NABL
$844M
$445K 0.03%
62,761
+51,589
+462% +$459K
MNKD icon
546
MannKind Corp
MNKD
$1.19B
$443K 0.03%
+88,118
New +$494K
EXAS
547
DELISTED
Exact Sciences
EXAS
$442K 0.03%
10,205
-21
-0.2% -$1.06K
DGICA icon
548
Donegal Group Class A
DGICA
$715M
$441K 0.03%
22,459
+8,754
+64% +$142K
EFXT
549
Enerflex
EFXT
$2.58B
$439K 0.03%
56,775
+12,015
+27% +$106K
MSBI icon
550
Midland States Bancorp
MSBI
$697M
$438K 0.03%
25,556
+12,165
+91% +$244K

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.